Diabetes 52:43-50, 2003
© 2003 by the American Diabetes Association, Inc.
Differential Regulation of Lipogenesis and Leptin Production by Independent Signaling Pathways and Rosiglitazone During Human Adipocyte Differentiation
Nayan G. Patel1,
Julie C. Holder2,
Stephen A. Smith2,
Sudesh Kumar1, and
Margaret C. Eggo1
1 Division of Medical Sciences, University of Birmingham, Birmingham, U.K.
2 GlaxoSmithKline, Harlow, Essex, U.K.
Since leptin levels are independently correlated with risk of coronary heart disease, we have identified signaling pathways important in mediating leptin production and lipogenesis in human preadipocytes. We used inhibitors of p70S6 kinase, p42/44 mitogen-activated protein kinase (MAPK), p38 MAPK, and phosphatidylinositol 3-kinase (PI3K). Human preadipocytes were induced to differentiate in insulin, dexamethasone, triiodothyronine, and 3-isobutyl-1-methylxanthine in the presence or absence of inhibitors and the peroxisome proliferator-activated receptor (PPAR)- activator rosiglitazone. Differentiation was assessed by measuring leptin secretion, lipid content, and lipogenic activity. Rosiglitazone increased cell protein by 15%, the lipid content of the cell layer was doubled, and the lipogenic activity increased sevenfold but did not stimulate leptin secretion. None of the inhibitors significantly inhibited protein content over 20 days, but lipid content and lipogenic activity were inhibited by p70S6 kinase and p38 MAPK inhibition but not by p42/44 MAPK or PI3K inhibition. All of the inhibitors significantly decreased leptin secretion, and these inhibitory effects were increased by coincubation with rosiglitazone. We conclude that PI3K and p42/44 MAPK pathways are not critical to the differentiation program leading to lipid accumulation, but stimulation of leptin secretion is dependent on these as well as the p70S6 kinase and p38 MAPK signaling pathways.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. S. Newell, H. Su, H. Tornqvist, J. P. Whitehead, J. B. Prins, and L. J. Hutley
Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation
FASEB J,
December 1, 2006;
20(14):
2615 - 2617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Patel, S. Kumar, and M. C. Eggo
Essential Role of Fibroblast Growth Factor Signaling in Preadipoctye Differentiation
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1226 - 1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|